Colonic Diseases  >>  cyclosporine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00003950: Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer

Completed
2
16
US
cyclosporine, Sandimmune®, Restatis®, CPT-11, Irinotecan, Camptosar®
University of Chicago, National Cancer Institute (NCI)
Colorectal Cancer
12/01
01/05
NCT01033305 / 2008-003169-19: Oral Ciclosporin for Colonic Release in Ulcerative Colitis (CyCol™)

Completed
2
118
Europe
CyCol™, Ciclosporin, Placebo, Sugar Pill
Sigmoid Pharma
Mild to Moderate Ulcerative Colitis
08/11
09/11

Download Options